Found: 21
Select item for more details and to access through your institution.
Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 3, p. 559, doi. 10.1007/s10549-018-4992-7
- By:
- Publication type:
- Article
Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2023.1202277
- By:
- Publication type:
- Article
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor.
- Published in:
- Nature Medicine, 2010, v. 16, n. 2, p. 205, doi. 10.1038/nm.2091
- By:
- Publication type:
- Article
Generation of “Virtual” Control Groups for Single Arm Prostate Cancer Adjuvant Trials.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0085010
- By:
- Publication type:
- Article
Plasma-Derived Exosomal Survivin, a Plausible Biomarker for Early Detection of Prostate Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0046737
- By:
- Publication type:
- Article
Kava Components Down-Regulate Expression of AR and AR Splice Variants and Reduce Growth in Patient-Derived Prostate Cancer Xenografts in Mice.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031213
- By:
- Publication type:
- Article
A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 3, p. 1, doi. 10.1002/ctm2.1627
- By:
- Publication type:
- Article
Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 525, p. 1, doi. 10.1126/scitranslmed.aay4860
- By:
- Publication type:
- Article
Differential expression of peroxiredoxins in prostate cancer: Consistent upregulation of PRDX3 and PRDX4.
- Published in:
- Prostate, 2011, v. 71, n. 7, p. 755, doi. 10.1002/pros.21292
- By:
- Publication type:
- Article
Racial Distribution of Neighborhood-Level Social Deprivation in a Retrospective Cohort of Prostate Cancer Survivors.
- Published in:
- Diseases, 2022, v. 10, n. 4, p. 75, doi. 10.3390/diseases10040075
- By:
- Publication type:
- Article
Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 10, p. 1, doi. 10.1038/leu.2012.276
- By:
- Publication type:
- Article
Development of cell-penetrating bispecific antibodies targeting the N-terminal domain of androgen receptor for prostate cancer therapy.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2017, v. 30, n. 12, p. 1, doi. 10.1093/protein/gzx058
- By:
- Publication type:
- Article
Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 3, p. 164, doi. 10.1002/ajh.21615
- By:
- Publication type:
- Article
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
PIM-1 kinase expression in adipocytic neoplasms: diagnostic and biological implications.
- Published in:
- International Journal of Experimental Pathology, 2010, v. 91, n. 1, p. 34, doi. 10.1111/j.1365-2613.2009.00673.x
- By:
- Publication type:
- Article
Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration‐resistant prostate cancer.
- Published in:
- Prostate, 2022, v. 82, n. 13, p. 1264, doi. 10.1002/pros.24400
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
- Published in:
- Oncologist, 2022, v. 27, n. 10, p. e815, doi. 10.1093/oncolo/oyac176
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
- Published in:
- Oncologist, 2022, v. 27, n. 9, p. e815, doi. 10.1093/oncolo/oyac176
- By:
- Publication type:
- Article
Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 4, p. 327, doi. 10.1634/theoncologist.2019-0115
- By:
- Publication type:
- Article